Reading Room Production — page 152

5 PM [AID DEA DART (0 DcR-0ccR AT IIAID) [E] I IIH/NIAID) [--] S is now requesting any y (9/27), cE 7PM [AID DEA DART NIH/NIAID) [E] NIH/NIAID) [E] I NIH/NIAID) [E] ay I == -- NIAID) (E] i I ID DIR-OCGR < ] (NIH/NIAID) [E] 4/NIAID) [E] VIH/NIAID) [E] iy >; (NIH/NIAID) [E] NIAID) [E] ndences ay > 'nate Committee on NIAID) [E] VIH/NIAID) [E] iy >; (NIH/NIAID) [E] NIAID) [E] DMID has suggested comments in highlighted Ww. Please let me know if you have any questions. From: Crawford, Chase (NIH/NIAID) [E] Sent: Wednesday, September 25, 2024 1:45 PM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; NIAID DCR-OCGR @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: ACTION by COB Friday (9/27): Review revised bill text for Risky Research Review Act Good Afternoon, NIAID has been asked to review the revised bill text for the Risky Research Review Act (PDF of bill text and Word doc of the redline are attached). This morning, the attached version of the bill was reported out of the Senate Committee on Homeland Security & Governmental Affairs (HSGAC) and now awaits further Senate consideration. As you may recall, NIH and other OPDIVs provided comments on a previous version of the bill (previous NIAID comments attached for reference). HHS is now requesting any new comments that OPDIVS may have. ACTION: By COB Friday (9/27), please review the attached redline and provide any new comments directly in the document. Thanks, Chase From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Tuesday, July 16, 2024 6:07 PM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: URGENT review by 8am Wed. 7/17: HHS Comments to OMB on Risky Research Review Act Importance: High Hello all, Thank you for your review of the consolidated HHS comments on the Risky Research Review Act. DMID has suggested adding some of the comments NIAID put forward earlier this week. We have incorporated these comments in highlighted text in the attached document. The comments are listed below by page number for ease of review. Please let us know by no later than 8am tomorrow, Wednesday, July 17th, if you have any concerns with putting forward these previously NIAID-cleared edits. Thank you again for all your help with this quick turnaround request. Please let me know if you have any questions.